These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2635678)

  • 1. [Serotonin antagonism--a new working principle. Blood pressure lowering and vasoprotection for the elderly hypertensive patient. Symposium of the 4th European meeting on hypertension. 18 June 1989, Milan].
    Fortschr Med Suppl; 1989; 72():1-15. PubMed ID: 2635678
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on serotonin and cardiovascular regulation: a new approach to hypertension. Satellite symposium of the Second European Meeting on Hypertension. 9 June 1985, Milan, Italy.
    J Hypertens Suppl; 1986 Apr; 4(1):S1-111. PubMed ID: 2939207
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serotonin and cardiovascular regulation: new aspects of hypertension. Satellite symposium of the Second European Meeting on Hypertension. Milan, 9 June 1985].
    Med Klin Suppl; 1985; 1():1-16. PubMed ID: 3870421
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive treatment of the active elderly patient. Satellite symposium to the 4th European Meeting on Hypertension. Milan, Italy, June 17, 1989. Proceedings.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S1-62. PubMed ID: 2483565
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium transport, blood pressure regulation and treatment of hypertension. Satellite symposium of the Third European Meeting on Hypertension. 12 June 1987, Milan, Italy.
    J Hypertens Suppl; 1987 Dec; 5(4):S1-145. PubMed ID: 3481631
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute effects of antagonist of S2-receptors.
    Petkovská N; Brimichová G; Tison P; Dzúrik R
    Czech Med; 1984; 7(4):210-4. PubMed ID: 6084584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Symposium. Ketanserin: Serotonin antagonism is a new therapeutic principle in the older hypertensive patient. 24 September 1988, Frankfurt. Abstracts].
    Internist (Berl); 1988 Dec; 29(12 Suppl):1-12. PubMed ID: 3065279
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly.
    O'Malley K; McCormack P; O'Brien ET
    J Hypertens Suppl; 1988 Nov; 6(1):S105-8. PubMed ID: 3063783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypertensive patient with multiple risk factors: clinical considerations. Satellite symposium to the Fourth European Meeting on Hypertension. 22 June 1989, Milan, Italy. Proceedings.
    J Hypertens Suppl; 1990 Mar; 8(1):S1-63. PubMed ID: 2332813
    [No Abstract]   [Full Text] [Related]  

  • 11. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symposium on decision-making in the management of hypertension. Satellite symposium of the Second European Meeting on Hypertension. 8 June 1985, Milan, Italy.
    J Hypertens Suppl; 1985 Nov; 3(2):S1-159. PubMed ID: 3866838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
    McCall RB; Clement ME
    Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380
    [No Abstract]   [Full Text] [Related]  

  • 15. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The progress of patients in the European Working Party on Hypertension in the Elderly trial.
    Amery A; Beard K; Birkenhäger W; Bogaert M; Brixko P; Bulpitt C; Clement D; de Leeuw P; De Plaen JF; Deruyettere M
    Acta Med Scand Suppl; 1983; 676():119-40. PubMed ID: 6362343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of treatment of the elderly hypertensive.
    Moser M
    Geriatrics; 1989 Oct; 44 Suppl B():30-6. PubMed ID: 2680778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of arterial hypertension in the elderly. Characteristics of hypertension in aging--use of calcium antagonists].
    Lohmann FW
    Fortschr Med; 1994 Sep; 112(26):350-4. PubMed ID: 7959510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to antihypertensive treatment. A satellite symposium of the First European Meeting on Hypertension, June 2, 1983, Milan.
    Hypertension; 1983; 5(5 Pt 2):III1-159. PubMed ID: 6629454
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ketanserin. Lowering blood pressure using serotonin antagonists].
    Uhl D
    Med Monatsschr Pharm; 1989 Oct; 12(10):298-301. PubMed ID: 2811738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.